Lomza State University of Applied Sciences Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2019
NCT03871322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Faculty of Health Sciences Lomza | Lomza State University of Applied Sciences

Active Ingredients

Drugs in Other Trials (2)

vitamin d3 (1 trial)

vitamin k2 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2